Liesl Altus ESA-SRB-ANZBMS 2024 in conjunction with ENSA

Abstracts this author is presenting:

• The South Australian (177) Lu-DOTATATE peptide receptor radionuclide therapy service - a focus on quality of life outcomes in the treatment of somatostatin-receptor positive tumours — ESA Poster Listing: Clinical